Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LadRx Corp stock logo
CYTR
LadRx
$0.09
$0.05
$0.86
$4.14MN/A99,706 shs4,000 shs
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
$30.95
-0.3%
$31.46
$29.67
$34.85
$2.48M1.15879 shs100 shs
FPXE
First Trust IPOX Europe Equity Opportunities ETF
$24.37
+1.5%
$24.74
$19.25
$25.60
$4.87M1428 shs4 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LadRx Corp stock logo
CYTR
LadRx
0.00%0.00%0.00%0.00%0.00%
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
0.00%0.00%0.00%0.00%+4.19%
FPXE
First Trust IPOX Europe Equity Opportunities ETF
-0.50%+1.74%-5.44%+7.33%+9.68%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LadRx Corp stock logo
CYTR
LadRx
N/AN/AN/AN/AN/AN/AN/AN/A
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
N/AN/AN/AN/AN/AN/AN/AN/A
FPXE
First Trust IPOX Europe Equity Opportunities ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LadRx Corp stock logo
CYTR
LadRx
N/AN/AN/AN/A
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
0.00
N/A$38.3623.96% Upside
FPXE
First Trust IPOX Europe Equity Opportunities ETF
0.00
N/A$26.348.09% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LadRx Corp stock logo
CYTR
LadRx
N/AN/AN/AN/AN/AN/A
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
N/AN/AN/AN/AN/AN/A
FPXE
First Trust IPOX Europe Equity Opportunities ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LadRx Corp stock logo
CYTR
LadRx
N/AN/A0.00N/AN/AN/AN/AN/AN/A
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
N/AN/A7.50N/AN/AN/AN/AN/A
FPXE
First Trust IPOX Europe Equity Opportunities ETF
N/AN/A17.67N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LadRx Corp stock logo
CYTR
LadRx
N/AN/AN/AN/AN/A
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
$0.250.81%N/AN/AN/A
FPXE
First Trust IPOX Europe Equity Opportunities ETF
$0.512.09%N/AN/A1 Years

Latest CYTR, DWMC, and FPXE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/20/2024
FPXE
First Trust IPOX Europe Equity Opportunities ETF
$0.05943/21/20243/22/20243/28/2024
(Data available from 1/1/2013 forward)

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
LadRx Corp stock logo
CYTR
LadRx
N/A45.04 millionN/ANot Optionable
DWMC
AdvisorShares Dorsey Wright Micro-Cap ETF
147,00080,000N/ANot Optionable
FPXE
First Trust IPOX Europe Equity Opportunities ETF
147,000200,000N/ANot Optionable

CYTR, DWMC, and FPXE Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

LadRx logo

LadRx

NASDAQ:CYTR
LadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.

AdvisorShares Dorsey Wright Micro-Cap ETF

NASDAQ:DWMC
The AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC) is an exchange-traded fund that is based on the Russell 3000 index. The fund is an actively managed portfolio of US-listed micro-cap stocks. The fund follows a rules-based momentum strategy and seeks long-term capital appreciation. DWMC was launched on Jul 10, 2018 and is managed by AdvisorShares.

First Trust IPOX Europe Equity Opportunities ETF

NASDAQ:FPXE
The First Trust IPOX Europe Equity Opportunities ETF (FPXE) is an exchange-traded fund that is based on the IPOX 100 Europe index, a market-cap-weighted index of the 100 largest European IPOs over the first 1,000 trading days for each stock. FPXE was launched on Oct 4, 2018 and is managed by First Trust.